Expression of the α3 nicotinic receptor subunit mRNA in aging and Alzheimer's disease

Molecular Brain Research

Volumn 63, Issue 1, 1998, Pages 72-78

  Terzano, Susanna ^a   Court, Jenny A ^b   Fornasari, Diego ^a   Griffiths, Martin ^b   Spurden, Dean P ^b   Lloyd, Stephen ^b   Perry, R H ^b   Perry, Elaine K ^b   Clementi, Francesco ^a  

^a CNR   (Italy)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Aging; Alzheimer's disease; Entorhinal cortex; Hippocampus; In situ hybridisation; Nicotinic receptor

Indexed keywords

NICOTINIC RECEPTOR; RECEPTOR SUBTYPE; MESSENGER RNA; NICOTINIC RECEPTOR SUBUNIT ALPHA3;

AGING; ALZHEIMER DISEASE; ARTICLE; BINDING SITE; CORRELATION FUNCTION; ENTORHINAL CORTEX; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; AGED; CHEMISTRY; FEMALE; GENE EXPRESSION; GENETICS; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MALE; PHYSIOLOGY; THALAMUS;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; ENTORHINAL CORTEX; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; HUMANS; IN SITU HYBRIDIZATION; MALE; RECEPTORS, NICOTINIC; RNA, MESSENGER; THALAMUS;

EID: 0032506609     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00260-5     Document Type: Article

References (42)

1. Arriagada P.V., Marzloff L., Hyman B.T. Distribution of Alzheimer-type pathological changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology. 42:1992;1681-1688.
2. Aubert I., Araujo D.M., Cecyre D., Robitaille Y., Gauthier S., Quirion R. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's disease. J. Neurochem. 58:1992;529-541.
3. Aubert I., Poirier J., Gauthioer S., Quirion R. Multiple cholinergic markers are unexpectedly not altered in the rat dentate gyrus following entorhinal cortex lesions. J. Neurosci. 14:1994;2476-2484.
4. Barton A.J.L., Pearson R.C.A., Najlerahim A., Harrison P.J. Pre- and Post-mortem influences on brain RNA. J. Neurochem. 61:1993;1-11.
5. Braak H., Braak E. Neuropathological staging of Alzheimer related changes. Acta Neuropathol. 82:1991;239-259.
6. Burke W.J., O'Malley K.L., Chung H.D., Harmon S.K., Miller P., Berg L. Effect of pre- and post-mortem variables on specific mRNA levels in human brain. Mol. Brain Res. 11:1991;37-41.
7. Cimino M., Marini P., Fornasari D., Cattabeni F., Clementi F. Distribution of nicotinic receptors in cynomolgus monkey brain and ganglia: localization of α3 subunit mRNA, a-bungarotoxin and nicotine binding sites. Neuroscience. 51:1992;77-86.
8. 3H )-dopamine release Br. J. Pharmacol. 117:1996;606-5965.
9. J.A. Court, E.K. Perry, Distribution of nicotinic receptors in the CNS, in: T.W. Stone (Ed.), CNS Neurotransmitters and Neuromodulators: Acetylcholine, CRS Press, Boca Raton, Fl, 1995, pp. 85-104.
10. Court J.A., Lloyd S., Johnson M., Griffith M., Birdsall N.J.M., Piggot M.A., Oakley A.E., Ince P.G., Perry E.K., Perry R.H. Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging. Dev. Brain Res. 101:1997;93-105.
11. Deutch A.Y., Holliday J., Roth R.H., Chun L.L.Y., Hawrot E. Immunohistochemical localization of a neuronal nicotinic acetylcholine receptor in mammalian brain. Proc. Nat. Acad. Sci. U.S.A. 84:1987;8697-8701.
12. Fornasari D., Chini B., Tarroni P., Clementi F. Molecular cloning of human neuronal nicotinic receptor α3 subunit. Neurosci. Lett. 111:1990;351-356.
13. Fornasari D., Battaglioli E., Flora A., Terzano S., Clementi F. Structural and functional characterization of the human α3 nicotinic subunit gene promoter. Mol. Pharmacol. 51:1997;250-261.
14. Giacobini E. Cholinergic receptors in human brain: effect of aging and Alzheimer's Disease. J. Neurosci. Res. 27:1990;548-560.
15. Gotti C., Fornasari D., Clementi F. Human neuronal nicotinic receptors. Prog. Neurobiol. 53:1997;199-237.
16. Haring J.H., Davis J.N. Differential distribution of locus coeruleus projections to the hippocampal formation: anatomical and biological evidence. Brain Res. 325:1985;366-369.
17. Harrison P.J., Pearson R.C.A. In situ hybridization histochemistry and the study of gene expression in the human brain. Prog. Neurobiol. 34:1990;271-312.
18. Hsu Y.-N., Amin J., Weiss D.S., Wecker L. Sustained nicotine exposure differentially affects α4β2 neuronal nicotinic receptors expressed in Xenopus oocytes. J. Neurochem. 66:1996;667-675.
19. Ince P., Irving D., McArthur F., Perry R.H. Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients. J. Neurol. Sci. 106:1991;142-152.
20. Jones G.M., Sahakian B.J., Levy R., Warburton D.M., Gray J.A. Effects of acute subcutaneous nicotine on attention, information processing and short term memory in Alzheimer's disease. Psycopharmacology. 108:1992;485-494.
21. Levin E.D. Nicotinic system and cognitive function. Psychopharmacology. 108:1992;417-431.
22. Lobron Ch., Wevers A., Damlgen K., Keske A., Rontal D., Birtsch Ch., Heinemann S., Reinhardt S., Maelicke A., Schroder H. Cellular distribution in the rat telencephalon of mRNA encoding for the α3 and α4 subunits of the nicotinic acetylcholine receptor. Mol. Brain Res. 30:1995;70-76.
23. Marks M.J., Pauly J.R., Gross S.D., Deneris E.S., Herman S., Borgmeyer I., Heinemann S.T., Collins A.C. Nicotine binding and nicotine receptor subunir RNA after chronic nicotine treatment. J. Neurosci. 12:1992;2765-2784.
24. McGehee D.M., Role L.W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 57:1995;521-546.
25. Morrow A.L., Loy R., Creese I. Alteration of nicotinic cholinergic agonist binding sites in hippocampus after fimbria transection. Brain Res. 334:1985;309-314.
26. Nakayama H., Nakashima T., Kurogichi Y. α4 is a major acetylcholine binding subunit of cholinergic ligand affinity-purified nicotinic acetylcholine receptor from rat brains. Neurosci. Lett. 121:1991;122-124.
27. Nordberg A. Neuroreceptor changes in Alzheimer disease. Cereb. Brain Metab. Rev. 4:1992;303-328.
28. Nordberg A., Alafuzoff I., Winblad B. Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia. J. Neurosci. Res. 31:1992;103-111.
29. Nordberg A. Human nicotinic receptors-their role in aging and dementia. Neurochem. Int. 25:1994;93-97.
30. J.M. Palacios, G. Mengod, G.B. Landwehrmeyer, Autoradiographic visualization of neurotransmitter binding sites and mRNSs in human brain, in: W.E. Stumpf, H.F. Solomon (Eds.), Autoradiography and Correlative Imaging, Academic Press, London, 1995, pp. 221-251.
31. Perry E.K., Perry R.H. Neurochemical pathology and therapeutic strategies in degenerative dementia. Int. Rev. Psychiatry. 5:1993;363-380.
32. Perry E.K., Morris C.M., Court J.A., Cheng A., Fairbairn A.F., McKeith I.G., Irving D., Brown A., Perry R.H. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience. 64:1995;385-395.
33. Rubboli F., Court J.A., Sala C., Morris C., Chini B., Perry E.K., Clementi F. Distribution of nicotinic receptors in the human hippocampus and thalamus. Eur. J. Neurosci. 6:1994;1596-1604.
34. Sahakian B., Jones G., Levy R., Gray J., Warburton D. The effects of nicotine on attention, information processing and short term memory in patients with dementia of the Alzheimer type. Br. J. Psychiatry. 154:1989;797-800.
35. Schroder H., de Vos R.A.I., Jansen E.N.H., Birtsch C., Wevers A., Lobron C., Nowacki S., Schroder R., Maelicke A. Gene expression of the nicotinic acetylcholine receptor α4 subunit in the frontal cortex in Parkinson's disease patients. Neurosci. Lett. 187:1995;173-177.
36. Sershen H., Balla A., Lajtha A., Vizi E.S. Characterization of nicotinic receptors involved in the release from the hippocampus. Neuroscience. 77:1997;121-130.
37. Smith C.J., Court J.A., Keith A.B., Perry E.K. Increases in muscarinic stimulated hydrolysis of inositol phosphates in rat hippocampus following cholinergic deafferentiation are not paralleled by alterations in cholinergic receptor density. Brain Res. 485:1989;317-324.
38. Tohgi H., Utsugisawa K., Yoshimura M., Nagane Y., Mihara M. Age-related changes in nicotinic acetylcholine receptor subunits α4 and β2 messenger RNA expression in postmortem human frontal cortex and hippocampus. Neurosci. Lett. 245:1998;139-142.
39. Wada E., Wada K., Boulter J., Deneris E., Heinemann S., Patrick J., Swanson L.W. Distribution of alpha 2, alpha 3, alpha 4 and beta 2 neuronal nicotinic receptor subunit mRNA in the central nervous system: a hybridization histochemical study in the rat. J. Comp. Neurol. 284:1989;314-335.
40. Warpman U., Nordberg A. Epibatidine and ABT 418 reveal selective loss of α4β2 nicotinic receptors in Alzheimer's brains. NeuroReport. 6:1995;2419-2423.
41. Wevers A., Jeske A., Lobron Ch., Birtsch Ch., Heinemann S., Schroder R., Schroder H. Cellular distribution of nicotinic acetylcholine receptor subunit mRNA in human cerebral cortex as revealed by non-isotopic in situ hybridization. Mol. Brain Res. 25:1994;122-128.
42. Xuereb J.H., Perry E.K., Candy J.M., Bonham J.R., Perry R.H., Marshall E. Parameter of cholinergic neurotransmission in the thalamus in the Parkinson's disease and Alzheimer's disease. J. Neurol. Sci. 99:1990;185-197.